Two-dimensional MR spectroscopy techniques

Details Two-dimensional MR spectroscopy techniques Two-dimensional MR spectroscopy techniques

2001-03-30

2003-09-09

Warden, Jill (Department: 1743)

Chemistry: analytical and immunological testing

Nuclear magnetic resonance, electron spin resonance or other...

C324S307000, C324S308000, C324S309000, C324S310000, C600S410000

Reexamination Certificate

active

06617169

ABSTRACT:

TECHNICAL FIELD
This invention relates to magnetic resonance (MR) techniques, and more particularly to two-dimensional (2-D) magnetic resonance spectroscopy (MRS) techniques.
BACKGROUND
Quantification of chemical concentration using one-dimensional (1-D) MR spectra involves integrating the entire spectrum of a chemical, including all its peaks, along the chemical shift axis to determine the area under the curve. This technique can generally be employed when interference with the spectrum of the chemical of interest by other chemicals is tolerably low. In many samples, including complex biological samples (e.g., the human brain), many chemicals contribute to the 1-D spectrum of the sample, making it difficult to identify and quantify a spectrum for a single chemical of interest. One dimensional MRS techniques have been developed to reduce this interference, such as the multiple quantum filtering spectral editing method, see, e.g., Warren et al.,
Journal of Chemical Physics,
73(5):2512, 1980. These 1-D techniques acquire averaged signals with a constant echo time (t
e
) and, therefore, the frequency dependence, or J dependence, of the MR signals is not utilized. Consequently, a peak that has a chemical shift coordinate close to a peak of the chemical of interest will overlap and thereby interfere with the nearby peak. In multiple quantum filtering spectral editing, a small residual of the interfering peak can materially alter the peak value of the edited peak of the chemical of interest. Addressing this issue generally involves precise calibration of editing pulse parameters.
Two-dimensional MRS resolves resonance peaks along an additional axis, a frequency axis (J axis), providing more information to differentiate chemical peaks. A 2-D MR spectrum maps frequency in the vertical dimension (D2) against chemical shift, which is the horizontal axis (D1). Thus, in 2-D MRS, peaks having similar chemical shifts can be distinguished in the frequency dimension. Using 2-D MRS (e.g., localized J-resolved 2-D MRS) to analyze samples containing multiple chemicals, peaks that could not be differentiated using 1-D MRS can be resolved, see, e.g., Ke et al.,
Psychiatry Research Neuroimaging,
100: 169, 2000; Ryner et al.,
Magnetic Resonance Imaging,
13(6):853, 1995; Weber,
Technology and Health Care
5:471, 1997, which are incorporated by reference.
MR signals from J-coupled protons are J modulated, or dependent on sin(&pgr;Jt
e
) or cos(&pgr;Jt
e
), where t
e
is the echo time. Each echo corresponds to a free induction decay (FID) signal, which is recorded as data. In J-resolved 2-D MRS experiments, MR signals are acquired using enough different t
e
values such that J modulations in signals can be assessed by performing a Fourier transform with respect to t
e
, see, e.g., W. P. Aue et al.,
Journal of Chemical Physics,
64:4226, 1976; R. R. Ernst et al.,
Principles of Nuclear Magnetic Resonance in One and Two Dimensions,
1988, which are incorporated by reference. According to the relationship between the time and frequency domains in Fourier transform theory, the increments in t
e
, &Dgr;t
e
, determine the bandwidth of the J-frequency dimension. The bandwidth is equal to the inverse of the increments in t
e
, 1/&Dgr;t
e
. In 2-D MRS, &Dgr;t
e
is selected to provide a bandwidth that covers the maximum J value of interest and can be adjusted to maximize frequency resolution and signal intensity. For most biological metabolites, J values range from 0 to 20 Hz. Therefore, to use 2-D MRS to assess metabolite concentrations in a region of the human brain, a suitable &Dgr;t
e
can be, e.g., 10 milliseconds (corresponding a bandwidth of 100 Hz) and can be adjusted to produce different bandwidths.
SUMMARY
The present invention concerns identifying appropriate peaks in 2-D MR spectra for 1-D extraction and comparing spectra for test samples to those obtained with reference samples to obtain quantitative measurements of chemical concentrations. These methods can be used to obtain information about, e.g., in vivo chemical concentrations in the human brain using 2-D MRS and offer advantages over 1-D MRS techniques. Test samples can be biological samples, e.g., human or animal tissue, or non-biological samples.
Identifying a suitable peak in a 2-D spectrum for analysis by 1-D extraction involves subjecting a reference sample to a MRS sequence, obtaining a 2-D MR spectrum of the reference sample, and selecting a peak for a chemical of interest in the 2-D MR spectrum by comparing the peaks in the 2-D MR spectrum. It is generally useful to identify peaks that are substantially distinct from other peaks in the 2-D spectrum to reduce interference from other resonance peaks. The peak that is identified can be the peak that is most distinct from any other peaks in the 2-D MR spectrum of the reference sample or the strongest peak that is substantially distinct from the other peaks in the 2-D MR spectrum. With a peak identified, a test sample comprising the chemical of interest is subjected to a MRS sequence, a 2-D MR spectrum of the test sample is obtained, and a 1-D spectrum, i.e., 1-D slice taken along the chemical shift axis, comprising the identified peak for the chemical of interest is extracted from the 2-D MR spectrum of the test sample.
This peak identification methodology can be applied to samples that contain multiple chemicals. If the identified peak for the chemical of interest overlaps with a peak associated with other chemicals in the 2-D MRS spectrum of the test sample, then the 2-D MRS for the reference sample comprising the chemical of interest can be reviewed again to identify the “next best” peak, i.e., another peak substantially distinct from other peaks in the reference sample. In addition, 1-D MR spectra can be extracted from the 2-D MR spectra of multiple test samples. These techniques can be used to observe chemical peaks in 2-D MR spectra that do not suffer from substantial interference with either other peaks from the same chemical or peaks from other chemicals in the test sample. The chemical of interest in these samples can be a metabolite, e.g. gamma-aminobutyric acid (GABA), creatine (Cre), N-acetyl aspartate (NAA), choline (Cho), glutamine, glutamate, alanine, taurine, myo-insitol, glucose, aspartate, or lactate. The identified peak for GABA can be at a chemical shift of about 2.94 ppm, and the identified peak for Cre can be at a chemical shift of about 3.08 ppm.
The invention also generally features methods for quantitative assessment of chemical concentrations. To obtain concentration data, two reference samples containing first and second chemicals, respectively, and a reference chemical (e.g., 3-(trimethylsilyl)-1-propane-sulfonic acid) are subjected to a MRS sequence to obtain 2-D MR spectra. One-dimensional MR spectra, each containing a peak for the first or second chemical, are extracted from these 2-D MR spectra. The selected peaks can be substantially distinct from any other peaks in the 2-D spectra.
Standardized measures of intensity are calculated for each reference sample using the extracted 1-D spectra. This measure of intensity (k) is a ratio of the area under the peak of the first or second chemical (A) in the extracted 1-D MR spectrum of the reference sample to the area under a peak of the reference chemical (A
ref
), multiplied by the concentration of the reference chemical (&rgr;
ref
), and divided by the concentration of the first or second chemical (&rgr;):
k
=(
A &rgr;
ref
)/(
A
ref
&rgr;).
Using the measures of intensity for the first and second chemicals, a comparison ratio (R
21
) equal to the ratio of the standardized measure of intensity for the second chemical (k
2
) to the standardized measure of intensity for the first chemical (k
1
) is calculated:
R
21
=k
2
/k
1
.
This comparison ratio can provide information about the relative concentrations of the first and second chemicals in a test sample. One-dimensional extractions from 2-D MR spectra of a test sample are obtained by subjecting a test sample including the first and the sec

Affiliated with

Also associated with

Rating

Two-dimensional MR spectroscopy techniques does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Two-dimensional MR spectroscopy techniques, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Two-dimensional MR spectroscopy techniques will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3016036